Production, analysis and bioactivity of recombinant vasoactive intestinal peptide analogs

Biochimie

Volumn 78, Issue 1, 1996, Pages 14-25

  Raingeaud, J ^a,b   Lavergne, F ^a,b   Lelievre, V ^c   Muller, J M ^c   Julien, R ^a   Cenatiempo, Y ^b  

^a UNIVERSITY OF LIMOGES   (France)

^b IBMIG Institut de Biologie Moleculaire et dIngenierie Genetique   (France)

^c UNIVERSITÉ DE POITIERS   (France)

Author keywords

Poly vasoactive intestinal polypeptide; Recombinant peptides; Vasoactive intestinal polypeptide analogs

Indexed keywords

ADENYLATE CYCLASE; BLOOD CLOTTING FACTOR 10A; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; HYDROXYLAMINE; RECOMBINANT PROTEIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COLON ADENOCARCINOMA; CONTROLLED STUDY; ENZYME ACTIVATION; ESCHERICHIA COLI; GENE EXPRESSION; GUINEA PIG; HUMAN; HUMAN CELL; MALE; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; POLYMERIZATION; PROTEIN DEGRADATION; RECEPTOR BINDING; SMOOTH MUSCLE RELAXATION; TANDEM REPEAT; TRACHEA MUSCLE;

ANIMALIA; CAVIA PORCELLUS; ESCHERICHIA COLI; SUS SCROFA;

EID: 0029965929     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-9084(96)81324-1     Document Type: Article

References (44)

1. Said SI, Mutt V (1970) Polypeptide with broad biological activity: Isolation from small intestine. Science 169, 1217-1218
2. Said SI, Rosenberg RN (1976) Vasoactive intestinal polypeptide: Abundant immunoreactivity in neural cell lines and normal nervous tissue. Science 192, 907-908
3. Said SI (1986) Vasoactive intestinal peptide. J Endocrinol Invest 9, 191-200
4. Said SI (1991) Vasoactive intestinal polypeptide, biologic role in health and disease. Trends Endocrinol Metab 2, 107-112
5. Said SI (1993) Vasoactive intestinal peptide: involvement of calmodulin and catalytic antibodies. Neurochem Int 23, 215-219
6. Muller JM, El Battari A, Ah-Kye A, Luis J, Ducret F, Pichon J, Marvaldi J (1985) Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT 29). Eur J Biochem 152, 107-114
7. Luis J, Muller JM, Abadie B, Martin JM, Marvaldi J, Pichon J (1986) Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT29). Eur J Biochem 156, 631-636
8. Misbin RI, Wolfe MM, Morris P, Buynitzky SJ, McGuigan JE (1982) Uptake of vasoactive intestinal peptide by rat liver. Am J Physiol 243, G103-G111
9. Hachisu M, Hiranuma T, Tani S, Lizuka T (1991) Enzymic degradation of helodermin and vasoactive intestinal polypeptide. J Pharmacobio-Dyn 14, 126-131
10. Paul S, Ebadi M (1993) Vasoactive intestinal peptide: its interaction with calmodulin and catalytic antibodies. Neurochem Int 23, 197-214
11. Gafvelin G, Andersson M, Dimaline R, Jornvall H, Mutt V (1988) Isolation of variant form of vasoactive intestinal polypeptide. Peptides 9, 469-474
12. Fahrenkrug J (1991) Glycine-extended processing intermediate of proVIP: a new form of VIP in the rat. Biochem Biophys Res Commun 178, 173-177
13. Li M, Hoshino M, Yanaihara N (1992) Isolation of large VIP-related peptides in human neuroblastoma. Biomed Res 13 (suppl 2), 47-50
14. Romualdi P, Lesa G, Donati A, Balboni G, Tomatis R, Ferri S (1992) Alterations in vasoactive intestinal polypeptide related peptides after pentylenetetrazole-induced seizures in rat brain. Eur J Pharmacol 229, 149-153
15. Bissonnette BM, Collen MJ, Adachi H, Jensen RT, Gardner JD (1984) Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini. Am J Physiol 246, 6710-6717
16. Brenneman DE, Eiden LE (1986) Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc Natl Acad Sci USA 83, 1159-1162
17. Turner JT, Jones SB, Bylund DB (1986) A fragment of vasoactive intestinal peptide, VIP (10-28), is an antagonist of VIP in the colon carcinoma cell line HT29. Peptides 7, 849-854
18. Yanish-Perron C, Vieira J, Messing J (1985) Improved M13 phage cloning vectors and hosts strains: nucleotide sequence of the M13 mp18 and pUC19 vectors. Gene 33, 103-119
19. Hanahan D (1983) Study on transformation of Escherichia coli with plasmids. J Mol Biol 166, 557-580
20. Smith DB, Johnson KS (1988) Single step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67, 31-40
21. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
22. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74, 5463-5467
23. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
24. Matsudaira PT, Burgess DR (1978) SDS microslab linear gradient polyacrylamide gel electrophoresis. Anal Biochem 87, 386-396
25. Bornstein P, Balian G (1977) Cleavage at Asn-Gly bonds with hydroxylamine. Methods Enzymol 47, 132-145
26. Lipton SA (1994) HIV displays its coat of arms. Nature 367, 113-114
27. Simoncsits A, Tjornhammar ML, Kalman M, Cserpan I, Gafvelin G, Bartfai, T (1988) Synthesis, cloning and expression in Escherichia coli of artificial genes coding for biologically active elongated precursors of the vasoactive intestinal polypeptide. Eur J Biochem 178, 343-350
28. Wulff BS, Georg B, Farhenkrug J (1994) Expression and characterization of VIP and two VIP mutants in NIH 3T3 cells. FEBS Lett 341, 43-48
29. Knott JA, Sullivan CA, Weston A (1988) The isolation and characterization of the human natriuretic factor produced as a fusion protein in Escherichia coli. Eur J Biochem 174, 405-410
30. Shen S-H (1984) Multiple joined genes prevent product degradation in E coli. Proc Natl Acad Sci USA 81, 4627-4631
31. Kempe T, Chow F, Fass DN, Heath H (1988) (Homoserine31)-salmon calcitonin I: fully active analogue of calcitonin synthesized by recombinant DNA techniques. Bio/Tech 6, 190-192
32. Kempe T, Kent S, Chow F, Peterson SM, Sundquist WI, L'Italien JJ, Harbrecht D, Plunkett D, DeLorbe WJ (1985) Multiple-copy genes: production and modification of monomeric peptides from large multimeric fusion protein. Gene 39, 239-245
33. Kempe T, Chow F, Peterson SM, Baker P, Hays W, Opperman G, L'Italien JJ, Long G, Paulson B (1986) Production and characterization of growth hormone releasing factor analogs through recombinant DNA and chemical techniques. Bio/Tech 4, 564-568
34. Shibui T, Uchida-Kamizano M, Teranashi Y (1988) A method for overproduction of a protein of a target gene in E coli. Agric Biol Chem 52, 2235-2241
35. Schein CH, Noteborn MH (1988) Formation of soluble recombinant proteins in E coli is favored by lower growth temperature. Bio/Tech 6, 291-294
36. Vachon G, Raingeaud J, Dérijard B, Julien R, Cenatiempo Y (1993) Domain of E coli translational initiation factor IF2 homologous to lambda cI repressor and displaying DNA binding activity. FEBS Lett 321, 241-246
37. He M, Jin L, Austen B (1993) Specificity of factor Xa in the cleavage of fusion proteins. J Protein Chem 12, 1-5
38. Forsberg G, Palm G, Ekebacke A, Josephson S, Hartmanis M (1990) Separation and characterization of modified variants of recombinant human insulin-like growth factor I derived from a fusion protein secreted from Escherichia coli. Biochem J 271, 357-363
39. Canova-Davis E, Eng M, Mukku V, Reifsnyder DH, Olson CV, Ling VT (1992) Chemical heterogeneity as a result of hydroxylamine cleavage of a fusion protein of human insulin-like growth factor I. Biochem J 285, 207-213
40. Geiger T, Clarke S (1987) Deamidation, isomerization and racemization at asparaginyl and aspartyl residues in peptides. J Biol Chem 262, 785-794
41. Teh-Yung Liu D (1992) Deamidation: a source of microheterogeneity in pharmaceutical proteins. TibTech 10, 364-369
42. Fontana A, Gross E (1986) In: Practical protein chemistry: a handbook (Darbre A, ed) J Wiley and Sons, London, 67-120
43. Desbuquois B (1974) The interaction of vasoactive intestinal polypeptide and secretin with liver-cell membranes. Eur J Biochem 46, 439-450
44. Laburthe M, Amiranoff B, Boige N, Rouyer-Fessard C, Tatemoto K, Moroder L (1983) Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin. FEBS Lett 159, 89-92